Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278)
Metadata
Show full item recordAuthor
Acosta, Yenny Y; Zafra, Maria Paz; Ojeda, Gloria; Seren Bernardone, Ilaria; Dianzani, Umberto; Portolés, Pilar; Rojo, Jose MEditorial
Springer
Materia
PI3-Kinase Inducible costimulator ICOS T lymphocyte
Date
2011Referencia bibliográfica
Acosta YY, Zafra MP, Ojeda G, Bernardone IS, Dianzani U, Portolés P, Rojo JM. Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278). Cell Mol Life Sci. 2011 Sep;68(18):3065-79
Sponsorship
Y.Y.A. is the recipient of a Predoctoral Fellowship of the ‘‘Junta de Ampliación de Estudios’’ (JAE) Program (C.S.I.C., Ministerio de Ciencia e Innovacio´n, Spain). P.P. is a Tenured Sciencist of C.S.I.C. at the Centro Nacional de Microbiología, I.S.: Carlos III. This work was supported by grants PI070620 and PI070484 (Fondo de Investigación Sanitaria, Ministerio de Ciencia e Innovacio´n, Spain) and by AIRC (Milan) (to U.D.).Abstract
To better understand T lymphocyte costimulation by inducible costimulator (ICOS; H4; CD278), we analyzed proteins binding to ICOS peptides phosphorylated at the Y(191)MFM motif. Phosphorylated ICOS binds class IA phosphatidyl inositol 3-kinase (PI3-K) p85α, p50-55α and p85β regulatory subunits and p110α, p110δ and p110β catalytic subunits. Intriguingly, T cells expressed high levels of both p110α or p110δ catalytic subunits, yet ICOS peptides, cell surface ICOS or PI3-kinase class IA regulatory subunits preferentially coprecipitated p110α catalytic subunits. Silencing p110α or p110δ partially inhibited Akt/PKB activation induced by anti-CD3 plus anti-ICOS antibodies. However, silencing p110α enhanced and silencing p110δ inhibited Erk activation. Both p110α- and p110δ-specific inhibitors blocked cytokine secretion induced by TCR/CD3 activation with or without ICOS costimulus, but only p110α inhibitors blocked ICOS-induced cell elongation. Thus, p110α and p110δ are essential to optimal T cell activation, but their abundance and activity differentially tune up distinct ICOS signaling pathways.